Cite

    Lang, A. et al. (n.d.). A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years. Journal of clinical pharmacy and therapeutics. pp. 391-397. [Online].